A comparison of low-dose and high-dose protocols of vaginal misoprostol for second trimester termination of pregnancy
dc.contributor.buuauthor | Özerkan, Kemal | |
dc.contributor.buuauthor | Ocakoğlu, Gökhan | |
dc.contributor.buuauthor | Rehimli, S. | |
dc.contributor.buuauthor | Uncu, Gürkan | |
dc.contributor.buuauthor | Develioğlu, Osman H. | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Kadın Hastalıkları ve Doğum Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Biyoistatistik Anabilim Dalı. | tr_TR |
dc.contributor.researcherid | AAH-9791-2021 | tr_TR |
dc.contributor.researcherid | AAH-5180-2021 | tr_TR |
dc.contributor.scopusid | 6603345841 | tr_TR |
dc.contributor.scopusid | 15832295800 | tr_TR |
dc.contributor.scopusid | 25936644900 | tr_TR |
dc.contributor.scopusid | 6603716169 | tr_TR |
dc.contributor.scopusid | 6701315440 | tr_TR |
dc.date.accessioned | 2022-03-04T06:15:07Z | |
dc.date.available | 2022-03-04T06:15:07Z | |
dc.date.issued | 2009 | |
dc.description.abstract | Sixty patients were randomized to low-dose and high-dose groups, receiving a maximum total dose 1400 g of misoprostol by the vaginal route to compare the efficacy of the protocols for second trimester termination of pregnancy. Outcome measures to be compared between the groups were Success rates, time to termination, blood loss, complications and side-effects. Yet time to termination was significantly shorter in the high-close than in the low-dose group (923 +/- 571 vs 1307 +/- 828 min; p < 0.05). The distance between the internal cervical os and the placenta was positively correlated with the duration of the termination process (r = 0.508, p < 0.001). Induction to the fetal expulsion period is shorter with the higher dose without any significant increase in morbidity. A shorter distance between the internal cervical os and the placenta may forecast a shorter termination process. | en_US |
dc.identifier.citation | Özerkan, K. vd. (2009). "A comparison of low-dose and high-dose protocols of vaginal misoprostol for second trimester termination of pregnancy". Clinical and Experimental Obstetrics and Gynecology, 36(4), 245-247. | en_US |
dc.identifier.endpage | 247 | tr_TR |
dc.identifier.issn | 0390-6663 | |
dc.identifier.issue | 4 | tr_TR |
dc.identifier.pubmed | 20101858 | tr_TR |
dc.identifier.scopus | 2-s2.0-73949097273 | tr_TR |
dc.identifier.startpage | 245 | tr_TR |
dc.identifier.uri | http://hdl.handle.net/11452/24818 | |
dc.identifier.volume | 36 | tr_TR |
dc.identifier.wos | 000272203800015 | |
dc.indexed.pubmed | Pubmed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | IMR Press | en_US |
dc.relation.journal | Clinical and Experimental Obstetrics and Gynecology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Induced abortion | en_US |
dc.subject | Misoprostol | en_US |
dc.subject | Pregnancy | en_US |
dc.subject | Second trimester | en_US |
dc.subject | Randomized controlled-trial | en_US |
dc.subject | 2nd-trimester pregnancy | en_US |
dc.subject | Intravaginal misoprostol | en_US |
dc.subject | Oral misoprostol | en_US |
dc.subject | 2 regimens | en_US |
dc.subject | Obstetrics & gynecology | en_US |
dc.subject.emtree | Misoprostol | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Analytical parameters | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Bleeding | en_US |
dc.subject.emtree | Clinical examination | en_US |
dc.subject.emtree | Clinical feature | en_US |
dc.subject.emtree | Clinical protocol | en_US |
dc.subject.emtree | Clinical trial | en_US |
dc.subject.emtree | Controlled clinical trial | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Drug dose comparison | en_US |
dc.subject.emtree | Drug efficacy | en_US |
dc.subject.emtree | Echography | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Low drug dose | en_US |
dc.subject.emtree | Major clinical study | en_US |
dc.subject.emtree | Morbidity | en_US |
dc.subject.emtree | Operation duration | en_US |
dc.subject.emtree | Outcome assessment | en_US |
dc.subject.emtree | Placenta | en_US |
dc.subject.emtree | Prediction | en_US |
dc.subject.emtree | Pregnancy termination | en_US |
dc.subject.emtree | Randomized controlled trial | en_US |
dc.subject.emtree | Second trimester pregnancy | en_US |
dc.subject.mesh | Abortifacient agents, nonsteroidal | en_US |
dc.subject.mesh | Abortion, induced | en_US |
dc.subject.mesh | Drug administration schedule | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Misoprostol | en_US |
dc.subject.mesh | Pregnancy | en_US |
dc.subject.mesh | Pregnancy trimester, second | en_US |
dc.subject.scopus | Induced Labor; Pregnancy; Misoprostol | en_US |
dc.subject.wos | Obstetrics & gynecology | en_US |
dc.title | A comparison of low-dose and high-dose protocols of vaginal misoprostol for second trimester termination of pregnancy | en_US |
dc.type | Article | |
dc.wos.quartile | Q4 | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: